Orbimed Advisors Llc - Insider Trading & Ownership

Entity
Company
Location
601 Lexington Avenue, 54 Th Floor, New York, New York
Summary
The estimated value of insider holdings of Orbimed Advisors Llc is at least $958 M dollars as of July 2, 2024. Orbimed Advisors Llc is the 10%+ Owner of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $233 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $228 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $170 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $59.5 M. Orbimed Advisors Llc is the 10%+ Owner of NeuroPace Inc and owns shares of NeuroPace Inc (NPCE) stock worth about $47.8 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $38.2 M. Orbimed Advisors Llc is the 10%+ Owner of scPharmaceuticals Inc. and owns shares of scPharmaceuticals Inc. (SCPH) stock worth about $34 M. Orbimed Advisors Llc is the Director of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $30.3 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Compass Therapeutics, Inc. and owns shares of Compass Therapeutics, Inc. (CMPX) stock worth about $29.4 M. Orbimed Advisors Llc is the 10%+ Owner of 89bio, Inc. and owns shares of 89bio, Inc. (ETNB) stock worth about $21.1 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $18.5 M. Orbimed Advisors Llc is the 10%+ Owner of TELA Bio, Inc. and owns shares of TELA Bio, Inc. (TELA) stock worth about $10.9 M. Orbimed Advisors Llc is the Director of Disc Medicine, Inc. and owns shares of Disc Medicine, Inc. (IRON) stock worth about $8.47 M. Orbimed Advisors Llc is the Director of Verona Pharma plc and owns shares of Verona Pharma plc (VRNA) stock worth about $7.46 M. Orbimed Advisors Llc is the 10%+ Owner of Passage BIO, Inc. and owns shares of Passage BIO, Inc. (PASG) stock worth about $7.31 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $3.01 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Acutus Medical, Inc. and owns shares of Acutus Medical, Inc. (AFIB) stock worth about $2.62 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Corvus Pharmaceuticals, Inc. and owns shares of Corvus Pharmaceuticals, Inc. (CRVS) stock worth about $2.5 M. Orbimed Advisors Llc is the 10%+ Owner of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $1.47 M. Orbimed Advisors Llc is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $1.36 M. Orbimed Advisors Llc is the Director, 10%+ Owner of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (FIXX) stock worth about $1.29 M. Orbimed Advisors Llc is the 10%+ Owner of Galecto, Inc. and owns shares of Galecto, Inc. (GLTO) stock worth about $1.13 M. Orbimed Advisors Llc is the Other* of Traws Pharma, Inc. and owns shares of Traws Pharma, Inc. (ONTX) stock worth about $941 K. Orbimed Advisors Llc is the Director of Ikena Oncology, Inc. and owns shares of Ikena Oncology, Inc. (IKNA) stock worth about $489 K. Orbimed Advisors Llc is the Director, 10%+ Owner of Xtant Medical Holdings, Inc. and owns shares of Xtant Medical Holdings, Inc. (XTNT) stock worth about $263 K. Orbimed Advisors Llc is the Director of Repare Therapeutics Inc. and owns shares of Repare Therapeutics Inc. (RPTX) stock worth about $233 K.
All Insider Reports
All Insider Reports

Ownership of Orbimed Advisors Llc

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SWTX SpringWorks Therapeutics, Inc. 10%+ Owner $233 M Sep 12, 2022
EWTX Edgewise Therapeutics, Inc. Director, 10%+ Owner $228 M +$5 M +2.24% Jan 23, 2024
ELVN Enliven Therapeutics, Inc. Director, 10%+ Owner $170 M -$22.9 M -11.9% May 16, 2024
THRD Third Harmonic Bio, Inc. Director, 10%+ Owner $59.5 M Sep 19, 2022
NPCE NeuroPace Inc 10%+ Owner $47.8 M -$8.69 M -15.4% May 1, 2024
PRLD Prelude Therapeutics Inc Director, 10%+ Owner $38.2 M May 22, 2023
SCPH scPharmaceuticals Inc. 10%+ Owner $34 M Nov 25, 2022
SPRY ARS Pharmaceuticals, Inc. Director $30.3 M +$3.1 M +11.4% Aug 29, 2023
CMPX Compass Therapeutics, Inc. Director, 10%+ Owner $29.4 M Nov 8, 2022
ETNB 89bio, Inc. 10%+ Owner $21.1 M Jan 25, 2022
TERN Terns Pharmaceuticals, Inc. Director, 10%+ Owner $18.5 M Dec 23, 2022
TELA TELA Bio, Inc. 10%+ Owner $10.9 M -$2.02 M -15.6% Jun 28, 2024
IRON Disc Medicine, Inc. Director $8.47 M -$29.6 M -77.7% Jun 17, 2024
VRNA Verona Pharma plc Director $7.46 M May 11, 2023
PASG Passage BIO, Inc. 10%+ Owner $7.31 M Jun 27, 2023
ACET Adicet Bio, Inc. Director, 10%+ Owner $3.01 M +$7.5 M Jan 25, 2024
AFIB Acutus Medical, Inc. Director, 10%+ Owner $2.62 M Jul 19, 2021
CRVS Corvus Pharmaceuticals, Inc. Director, 10%+ Owner $2.5 M +$2.5 M May 6, 2024
ARQT Arcutis Biotherapeutics, Inc. 10%+ Owner $1.47 M Jun 24, 2022
JANX Janux Therapeutics, Inc. Director $1.36 M Dec 29, 2021
FIXX Q32 Bio Inc. Director, 10%+ Owner $1.29 M Mar 25, 2024
GLTO Galecto, Inc. 10%+ Owner $1.13 M -$1.83 M -61.7% Aug 15, 2023
ONTX Traws Pharma, Inc. Other* $941 K Apr 1, 2024
IKNA Ikena Oncology, Inc. Director $489 K Aug 4, 2023
XTNT Xtant Medical Holdings, Inc. Director, 10%+ Owner $263 K Aug 15, 2022
RPTX Repare Therapeutics Inc. Director $233 K Sep 3, 2021
ALPN ALPINE IMMUNE SCIENCES, INC. Director $0 -$28.7 M -100% May 18, 2024
KNTE Kinnate Biopharma Inc. Director, 10%+ Owner $0 Apr 3, 2024
THRX Theseus Pharmaceuticals, Inc. Director, 10%+ Owner $0 +$1.46 M Feb 14, 2024
AVBP ArriVent BioPharma, Inc. Director, 10%+ Owner Jan 30, 2024
PMVP PMV Pharmaceuticals, Inc. 10%+ Owner -$196 K Nov 22, 2023
SRRA Sierra Oncology, Inc. Director, 10%+ Owner Jul 1, 2022
TCDA Tricida, Inc. Director, 10%+ Owner Nov 22, 2022
TSBX Turnstone Biologics Corp. Director, 10%+ Owner +$5 M Jul 20, 2023

Insider Transactions Reported by Orbimed Advisors Llc:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership